Understanding Cardiovascular Risk in Prostate Cancer: Role of Disparities, Diabetes, and Aging

被引:1
作者
Nain, Priyanshu [1 ,2 ,3 ]
Seth, Lakshya [4 ]
Patel, Vraj [4 ]
Jiang, Stephanie [4 ]
Gopu, Gaurav [4 ]
Singh, Rishabh [5 ]
Stabellini, Nickolas [1 ,2 ,6 ]
Reddy, Ritu [4 ]
Weintraub, Neal L. [1 ,2 ]
Harris, Ryan A. [7 ]
Cullen, Jennifer [6 ,8 ]
Agarwal, Neeraj [9 ]
Moore, Justin Xavier [10 ]
Sayed, Nazish [11 ]
Guha, Avirup [1 ,2 ,3 ]
机构
[1] Augusta Univ, Med Coll Georgia, Dept Med, Div Cardiol, 1120,15th St, Augusta, GA 30901 USA
[2] Med Coll Georgia Augusta Univ, Vasc Biol Ctr, 1120, 15th St, Augusta, GA 30901 USA
[3] Augusta Univ, Med Coll Georgia, Dept Med, Cardiooncol Program, 1120,15th St, Augusta, GA 30901 USA
[4] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[5] Univ Illinois, Coll Med Peoria, Dept Internal Med, Peoria, IL USA
[6] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[7] Augusta Univ, Georgia Prevent Inst, Augusta, GA USA
[8] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH USA
[9] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[10] Univ Kentucky, Markey Canc Ctr, Ctr Hlth Equ Transformat,Dept Behav Sci,Coll Med, Community Impact Off,Dept Internal Med, Lexington, KY USA
[11] Stanford Univ, Cardiovasc Inst, Dept Surg, Div Vasc Surg, Palo Alto, CA USA
基金
美国国家卫生研究院;
关键词
Prostate cancer; Cardiovascular disease; Social determinants of health; Diabetes; Aging; ANDROGEN-DEPRIVATION THERAPY; METFORMIN USE; ARTERIAL STIFFNESS; FINANCIAL TOXICITY; HEALTH LITERACY; MEN; DISEASE; MORTALITY; ASSOCIATION; SUPPRESSION;
D O I
10.1007/s11936-024-01035-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewThe primary objective of this review article is to dissect the intricate relationship between disparities, aging, diabetes, and their collective influence on cardiovascular disease (CVD) risk in prostate cancer (PC) patients. We sought to answer how these determinants interact with each other and contribute to the varying CVD outcomes observed in different subsets of PC patients.Recent findingsIt has become evident that social determinants of health (SDOH) significantly impact PC outcomes. Particularly, cardiovascular outcomes in non-Hispanic Black (NHB) patients, those from lower socioeconomic backgrounds, and residing in rural areas are notably worse. Diabetes, a growing concern worldwide, has been linked to increased PC-specific and all-cause mortality. Interestingly, recent studies highlight the potential of metformin therapy in enhancing survival rates, especially pivotal for those undergoing androgen deprivation therapy (ADT). Furthermore, the implications of age on PC are profound. The age-driven alterations in factors like allostatic load, responses to ADT, and vascular health play a crucial role in influencing CVD outcomes.SummaryOur article highlights the multifaceted factors influencing cardiovascular risk in PC patients. Social disparities, aging, and diabetes mellitus significantly shape CVD outcomes. A holistic approach that targets both systemic and individual concerns, focusing on bridging healthcare access gaps and devising effective diabetes management strategies, is imperative. Metformin therapy emerges as a beacon of hope, especially for those patients on ADT. To improve cardiovascular outcomes in PC patients, there is an urgent need to target modifiable risk factors, emphasizing special attention to vulnerable populations. Further research is still needed to develop targeted interventions to mitigate the risk of disparities while improving cardiovascular outcomes, especially in vulnerable populations.
引用
收藏
页码:93 / 109
页数:17
相关论文
共 103 条
[1]  
Addison D, EQUITY CARDIO ONCOLO
[2]   Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review [J].
Ahn, Hyun Kyu ;
Lee, Young Hwa ;
Koo, Kyo Chul .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) :1-18
[3]  
[Anonymous], 2017, LANCET, V389, P881, DOI 10.1016/S0140-6736(17)30640-2
[4]   Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes [J].
Azoulay, Laurent ;
Dell'Aniello, Sophie ;
Gagnon, Bruno ;
Pollak, Michael ;
Suissa, Samy .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (02) :337-344
[5]   Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial [J].
Barocas, Daniel A. ;
Grubb, Robert, III ;
Black, Amanda ;
Penson, David F. ;
Fowke, Jay H. ;
Andriole, Gerald ;
Crawford, E. David .
CANCER, 2013, 119 (12) :2223-2229
[6]   Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis [J].
Bosco, Cecilia ;
Crawley, Danielle ;
Adolfsson, Jan ;
Rudman, Sarah ;
Van Hemelrijck, Mieke .
PLOS ONE, 2015, 10 (03)
[7]   Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms [J].
Bu, Yizhi ;
Peng, Mei ;
Tang, Xinyi ;
Xu, Xu ;
Wu, Yifeng ;
Chen, Alex F. ;
Yang, Xiaoping .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (19) :4886-4903
[8]  
Cai JJ, 2016, J GERIATR CARDIOL, V13, P183, DOI 10.11909/j.issn.1671-5411.2016.02.003
[9]   Cardiovascular Health in African Americans A Scientific Statement From the American Heart Association [J].
Carnethon, Mercedes R. ;
Pu, Jia ;
Howard, George ;
Albert, Michelle A. ;
Anderson, Cheryl A. M. ;
Bertoni, Alain G. ;
Mujahid, Mahasin S. ;
Palaniappan, Latha ;
Taylor, Herman A., Jr. ;
Willis, Monte ;
Yancy, Clyde W. .
CIRCULATION, 2017, 136 (21) :E393-E423
[10]   Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study [J].
Cesari, M ;
Penninx, BWJH ;
Newman, AB ;
Kritchevsky, SB ;
Nicklas, BJ ;
Sutton-Tyrrell, K ;
Rubin, SM ;
Ding, JZ ;
Simonsick, EM ;
Harris, TB ;
Pahor, M .
CIRCULATION, 2003, 108 (19) :2317-2322